611523

AstraZeneca Pharmaceuticals, LP — FEI 2517100

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 10, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Newark, DE (United States)